Last reviewed · How we verify

NCT03989973

Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis

Status unknown Last updated 18 June 2019
What this trial tests

trial testing Gastroscopy in Liver Cirrhosis in 500 participants. Status unknown.

Timeline
1 September 2016
Primary endpoint
1 September 2022
1 September 2023

Quick facts

Lead sponsorWest China Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment500
Start date1 September 2016
Primary completion1 September 2022
Estimated completion1 September 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

West China Hospital

Who can join

Adults 16 to 80, any sex, with Liver Cirrhosis or Esophageal Varices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this retrospective study was to investigate the diagnostic performance of 2D-SWE for predicting the presence of esophageal varices and high-risk varices in patients with liver cirrhosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Gastroscopy

Trials testing the same drug.

Other recruiting trials for Liver Cirrhosis

Currently open trials in the same condition.

Other West China Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03989973.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing